Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics
The Oncologist · 17.01.2026 · 31 (2)
DOI: 10.1093/oncolo/oyaf409 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Oncologist, online erschienen am 23.01.2026. Verfasst von Dianjie Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Xiangya Hospital at Central South University, Changsha 410011, Hunan, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Urinary Bladder Neoplasms, Exosomes, Circulating Tumor DNA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bladder cancer (BCa), marked by clinical heterogeneity and late diagnosis, remains a global health challenge. The limitations of conventional diagnostics have spurred the advancement of liquid biopsy approaches, which offer minimally invasive tools for early detection, prognosis, and therapeutic monitoring. This review highlights key components of liquid biopsy in BCa, including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes, and metabolomics—especially urinary volatile organic compounds (VOCs). Each modality contributes distinct insights into tumor biology: CTCs and ctDNA provide information on tumor genetics and dynamics; exosomes reflect microenvironmental signaling and lipid metabolism; and urinary VOC profiling enables metabolic characterization and early-stage discrimination. We explore how these dimensions complement each other in tracking disease progression, predicting recurrence, and guiding personalized therapy. Emphasis is placed on recent technological advances, clinical utility, and future integration into practice. This multidimensional perspective underscores the transformative potential of liquid biopsy in improving BCa outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Xiangya Hospital at Central South University, Changsha 410011, Hunan, China.
- Xiangya School of Medicine, Central South University, Changsha, Hunan 410078, China.
- Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
- Department of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, 410011, China.
ORCID-Profile: Dianjie Zeng, Jiachen Liu
Zitieren
APA
Zeng, D., Liu, B., Deng, F., Wang, Y., Liu, J., & Deng, Z. (2026). Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics. The Oncologist, 31(2). https://doi.org/10.1093/oncolo/oyaf409
Vancouver
Zeng D, Liu B, Deng F, Wang Y, Liu J, Deng Z. Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics. The Oncologist. 2026;31(2). doi:10.1093/oncolo/oyaf409
BibTeX
@article{Zeng2026,
author = {Zeng, Dianjie and Liu, Bojian and Deng, Fei and Wang, Yinhuai and Liu, Jiachen and Deng, Zebin},
title = {Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {2},
doi = {10.1093/oncolo/oyaf409}
}
EUVIMED